See more : IIFL Finance Limited (IIFL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of SHAMROCK INDUSTRIAL CO.LTD. (SHAMROIN.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SHAMROCK INDUSTRIAL CO.LTD., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Severn Trent Plc (SVT.L) Income Statement Analysis – Financial Results
- Ayvens (AYV.PA) Income Statement Analysis – Financial Results
- Option Care Health, Inc. (OPCH) Income Statement Analysis – Financial Results
- Prosperous Printing Company Limited (8385.HK) Income Statement Analysis – Financial Results
- CuraScientific Corp (CSTF) Income Statement Analysis – Financial Results
SHAMROCK INDUSTRIAL CO.LTD. (SHAMROIN.BO)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About SHAMROCK INDUSTRIAL CO.LTD.
Shamrock Industrial Co. Ltd. engages in the manufacturing of bulk pharmaceutical, and chemical products. It offers active pharmaceutical ingredients, advanced intermediates, intermediates, and fine chemicals. The company was founded on July 1, 1991 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -406.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -36.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 726.00K | 1.61M | 1.17M | 1.26M | 34.24M | 60.15K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 35.00K | 23.00K | 29.76K | 29.28K | 22.26K | 22.47K | 0.00 | 0.00 |
| SG&A | 1.52M | 761.00K | 1.64M | 1.20M | 1.29M | 34.26M | 82.63K | 588.84K | 709.01K |
| Other Expenses | 0.00 | 0.00 | 966.00K | 88.00K | 0.00 | 0.00 | 327.26K | 0.00 | -33.56M |
| Operating Expenses | 1.52M | 1.28M | 3.04M | 3.23M | 2.20M | 36.55M | 968.97K | 588.84K | 34.27M |
| Cost & Expenses | 1.52M | 1.28M | 3.04M | 3.23M | 2.20M | 36.55M | 968.97K | 588.84K | 34.27M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59M |
| Depreciation & Amortization | 0.00 | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 |
| EBITDA | -406.00K | -1.28M | -2.07M | -3.14M | -2.20M | -2.88M | -582.00K | -557.54K | -34.27M |
| EBITDA Ratio | -36.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -406.00K | -1.28M | -3.04M | -3.23M | -2.20M | -36.55M | -582.00K | -588.84K | -34.27M |
| Operating Income Ratio | -36.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 965.50K | 88.00K | 0.00 | 33.67M | -59.71K | 31.30K | 13.85M |
| Income Before Tax | -406.00K | -1.28M | -2.07M | -3.14M | -2.20M | -2.88M | -641.71K | -557.54K | -20.41M |
| Income Before Tax Ratio | -36.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 7.00K | -800.00 | -3.00 | -171.86K | -3.00 | -112.23K | -22.82K | 0.00 |
| Net Income | -406.00K | -1.29M | -2.07M | -3.14M | -2.20M | -2.88M | -641.71K | -557.54K | -20.41M |
| Net Income Ratio | -36.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.07 | -0.24 | -0.38 | -0.58 | -0.40 | -0.53 | -0.12 | -0.10 | -3.76 |
| EPS Diluted | -0.07 | -0.24 | -0.38 | -0.58 | -0.40 | -0.53 | -0.12 | -0.10 | -3.76 |
| Weighted Avg Shares Out | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M |
| Weighted Avg Shares Out (Dil) | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M |
Source: https://incomestatements.info
Category: Stock Reports